Before you merrily deck your halls, here's a guide to the potential dangers of plants traditionally associated with the festive season.
Includes a visual summary on the hazards of festive foliage #BMJInfographic@will_s_t#BMJChristmas https://t.co/Z69sbKGHp9
How do you map electrogram recording positions to surface interpolated data? #OpenEP (https://t.co/FBax6Hluqz) now provides several new ways (in beta!). See the Workflow here: https://t.co/BdIGqbiTco
@davidflatman@Channel5Sport@premrugby@MarkDurdenSmith Very disappointing. If I can’t watch a decent highlight package, I’ll not bother to read match reports. Will play other sports in the garden with boys, since they won’t be exposed and see skills -> potential life-long fans lost.
Therapeutic inertia during treatment initiation has long-term impact on BP control due to measurement error. @ChrisNFloyd and colleagues provide further evidence for the benefit of combination antihypertensive therapy. https://t.co/BZALaYOtV5
New on 1-dose @Pfizer vaccine after prior covid
"We show that individuals with previous #SARSCoV2 infection generate strong humoral and cellular responses to one dose of BNT162b2 vaccine, with evidence of high titres of in-vitro live virus neutralisation"
https://t.co/2G7TRu57OI
First #MedawarMedal presentation "NK cell spleen tyrosine kinase activation in antibody mediated rejection" – Candice Clarke of Imperial College #BTSNHSBT2021
Very reassuring to see that our vulnerable dialysis patients with positive SARS-CoV-2 antibodies are protected from reinfection up to 6 months later. https://t.co/qyaJTx8KsX
Good to see security guards requesting mask compliance @waitrose Whetstone today. Not a good look that one was ���mask exempt’ and potentially breathing over every customer.
Cost-Effectiveness of Initiating Pharmacological Treatment in Stage One Hypertension Based on 10-Year Cardiovascular Disease Risk: A Markov Modeling Study. @ChrisNFloyd https://t.co/QGJEvXShZ4
It kinda irks me when someone describes a vital sign or lab value as “incompatible with life.”
Here’s a @tweetorial all about the extremes of physiology.
Case #1:
A 10 yo ____ presents with the following vital signs.
T 109F RR 30 HR 300 BP 142/116
Fill in the blank
Our latest cost effectiveness paper on initiating Rx in stage 1 (Europe) Hypertension: Initiating treatment in stage 1 hypertension for people aged 60 is cost-effective regardless of 10-year CVD risk. https://t.co/Ro6rVLh81x